Skip to main content
Top

Seminars in Immunopathology

Issue 3/2017

Cancer and Autoimmunity

Content (10 Articles)

Introduction

Cancer and autoimmunity

Mads Hald Andersen

Review

T cell receptor repertoire usage in cancer as a surrogate marker for immune responses

David Schrama, Cathrin Ritter, Jürgen C. Becker

Open Access Review

Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, Mariusz A. Wasik, Ivan V. Litvinov, Lars Iversen, Erik Langhoff, Anders Woetmann, Niels Odum

Review

Myeloid-derived suppressor cells and tumor escape from immune surveillance

Viktor Umansky, Carolin Blattner, Viktor Fleming, Xiaoying Hu, Christoffer Gebhardt, Peter Altevogt, Jochen Utikal

Review

The role of dendritic cells in cancer

Morten Hansen, Mads Hald Andersen

Review

Anti-regulatory T cells

Mads Hald Andersen

Review

Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?

Franck Carbonnel, Emilie Soularue, Clélia Coutzac, Nathalie Chaput, Christine Mateus, Patricia Lepage, Caroline Robert

Review

Cancer immunotherapy in patients with preexisting autoimmune disorders

Marco Donia, Magnus Pedersen, Inge Marie Svane

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.